FDA Manufacturing Supplement Proposal To Be Discussed By Advisory Cmte.
Executive Summary
FDA's Pharmaceutical Sciences Advisory Committee will discuss the agency's proposal to reduce post-approval manufacturing change reporting requirements for "qualified " products during a Nov. 15-17 meeting.